These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1777935)

  • 1. Influence of isosorbide dinitrate concentration on its skin permeability from adhesive matrix devices.
    Hatanaka T; Oguchi M; Sugibayashi K; Morimoto Y
    Chem Pharm Bull (Tokyo); 1991 Jul; 39(7):1802-5. PubMed ID: 1777935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membrane permeation-controlled transdermal delivery system design. Influence of controlling membrane and adhesive on skin permeation of isosorbide dinitrate.
    Seki T; Kawaguchi T; Sugibayashi K; Juni K; Morimoto Y
    Chem Pharm Bull (Tokyo); 1990 Mar; 38(3):740-3. PubMed ID: 2347017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of vehicles and pressure sensitive adhesives on the penetration of isosorbide dinitrate across the hairless mouse skin.
    Myoung Y; Choi HK
    Drug Deliv; 2002; 9(2):121-6. PubMed ID: 12055040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential usefulness of solubility index for prediction of the skin permeation rate of 5-ISMN from pressure-sensitive adhesive tape.
    Sato K; Mitsui N; Hasegawa T; Sugibayashi K; Morimoto Y
    J Control Release; 2001 Jun; 73(2-3):269-77. PubMed ID: 11516504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous pharmacodynamics of transdermally delivered isosorbide dinitrate.
    Hori M; Ohtsuka S; Sunami M; Guy RH; Maibach HI
    Pharm Res; 1990 Dec; 7(12):1298-301. PubMed ID: 2095569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies on transdermal delivery system of isosorbide dinitrate].
    Ji AM; Jiang XT; Wang XF; Zou HQ
    Yao Xue Xue Bao; 1992; 27(11):858-63. PubMed ID: 1300032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Difference in the enhancing effects of ultrasound on the skin permeation of polar and non-polar drugs.
    Ueda H; Ogihara M; Sugibayashi K; Morimoto Y
    Chem Pharm Bull (Tokyo); 1996 Oct; 44(10):1973-6. PubMed ID: 8904829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a membrane-controlled transdermal therapeutic system containing isosorbide dinitrate.
    Ocak F; Ağabeyoğlu I
    Int J Pharm; 1999 Apr; 180(2):177-83. PubMed ID: 10370188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of penetration enhancers on isosorbide dinitrate penetration through rat skin from a transdermal therapeutic system.
    Gabiga H; Cal K; Janicki S
    Int J Pharm; 2000 Apr; 199(1):1-6. PubMed ID: 10794921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability and metabolism of isosorbide dinitrate from a transdermal spray.
    Laufen H; Leitold M
    Arzneimittelforschung; 1992 Jul; 42(7):931-5. PubMed ID: 1418058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel transdermal patch incorporating isosorbide dinitrate with bisoprolol: in vitro and in vivo characterization.
    Zhao JH; Fu JH; Wang SM; Su CH; Shan Y; Kong SJ; Wang Y; Lu WL; Zhang H; Zhang S; Li L; Zhang EH; Wang L; Pei QL; Wang JC; Zhang X; Zhang Q
    Int J Pharm; 2007 Jun; 337(1-2):88-101. PubMed ID: 17267147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro-in vivo correlation of percutaneous absorption: isosorbide dinitrate and morphine hydrochloride.
    Hatanaka T; Katayama K; Koizumi T; Sugibayashi K; Morimoto Y
    Biol Pharm Bull; 1994 Jun; 17(6):826-30. PubMed ID: 7951147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electron beam irradiation: a novel technology for the development of transdermal system of isosorbide dinitrate.
    Kotiyan PN; Vavia PR; Bhardwaj YK; Sabarwal S; Majali AB
    Int J Pharm; 2004 Feb; 270(1-2):47-54. PubMed ID: 14726121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Concentration-time profile of isosorbide dinitrate and its metabolites in plasma following percutaneous resorption of a transdermal therapeutic system].
    Menke G; Schnellhammer R; Rietbrock N
    Arzneimittelforschung; 1987 Nov; 37(11):1301-3. PubMed ID: 3440041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hemodynamic effects of a transdermal formulation of isosorbide dinitrate and its pharmacokinetics in conscious dogs].
    Kogi K; Tanaka O; Kimura T; Saito T
    Nihon Yakurigaku Zasshi; 1982 Oct; 80(4):279-88. PubMed ID: 7152395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of electric foot shock on pharmacokinetics of isosorbide dinitrate orally administered to rats.
    Gomita Y; Furuno K; Araki Y
    Jpn J Pharmacol; 1989 Feb; 49(2):297-9. PubMed ID: 2733266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of different absorption enhancers on the intranasal absorption of isosorbide dinitrate in rats.
    Na L; Mao S; Wang J; Sun W
    Int J Pharm; 2010 Sep; 397(1-2):59-66. PubMed ID: 20599486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of electric foot shock on pharmacokinetics of isosorbide dinitrate subcutaneously administered to rats.
    Gomita Y; Furuno K; Araki Y
    Jpn J Pharmacol; 1989 Sep; 51(1):132-5. PubMed ID: 2810934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of skin surface lipid on the skin permeation of lidocaine from pressure sensitive adhesives.
    Cheng YH; Hosoya O; Sugibayashi K; Morimoto Y
    Biol Pharm Bull; 1994 Dec; 17(12):1640-4. PubMed ID: 7735210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of pressure-sensitive adhesives as a pretreatment material before application of topical drug formulations and a peeling tape for excess stratum corneum layers.
    Kikuchi K; Todo H; Sugibayashi K
    Chem Pharm Bull (Tokyo); 2014; 62(6):559-67. PubMed ID: 24881662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.